Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 5, 2011

View Archived Issues

Researchers uncover mechanism of action of epigenetic modifier UVI-5008

Nektar Therapeutics discloses novel opioid analgesic with low abuse potential

Results of phase II evaluation of evacetrapib presented

New biomarker identified in patients with myelodysplastic syndromes

Further clinical data on REGN-727 reported

Nerviano Medical Sciences presents preclinical findings on NMS-P948

AZT-2 enhances neurotransmission in preclinical models

REG2 Anticoagulation System evaluated in humans

Radikal Therapeutics presents new bifunctional PARP inhibitors

Novel mineralocorticoid receptor antagonists prepared by Pfizer

Sentinel Oncology synthesizes novel Chk1 inhibitors

Researchers at GlaxoSmithKline disclose new EZH2 inhibitors

Genentech and Gilead Sciences jointly prepare new BTK inhibitors

Sanofi recruits patients in phase I/II trial of SAR-113945

Bristol-Myers Squibb collaborates with Tibotec Pharmaceuticals on phase II HCV trial

Titan Pharmaceuticals reports FDA regulatory guidance for Probuphine NDA

Adventrx and FDA discuss development of ANX-188

Stellar Pharmaceuticals to acquire Tribute Pharmaceuticals

Bayer and Regeneron report integrated analysis of VIEW studies

Tissue Therapies enters partnerships for wound care product

GSK submits additional information to FDA for MenHibrix BLA

Cell Therapeutics provides update on MAA for Pixuvri

Kyowa Hakko Kirin launches new formulation of Nauzelin in Japan

Shire submits joint clinical trials proposal to confirm benefit of ProAmatine to FDA

Australian regulators to remove dextropropoxyphene-containing painkillers from the market

Amicus initiates phase II study of investigational chaperone with ERT in Pompe's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...